
AODT-0002
Tirzepatide
Dual GIP/GLP-1 receptor agonist. Superior weight loss efficacy with improved glycemic control in clinical trials.
- CAS
- 2023788-19-2
- Purity
- ≥99.47%
- Grade
- GMP
Priority Sales Hotline
Tap to chat with us

AODT-0002
Dual GIP/GLP-1 receptor agonist. Superior weight loss efficacy with improved glycemic control in clinical trials.
We use cookies
We use essential cookies to make our site work, and optional analytics & preference cookies to improve your experience. See our Cookie Policy.